← Alle mensen

LP

L Pusztai

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-po...

Annals of oncology : official journal of the European Society for Medical Oncology · 2026-02

Pathologic complete response (pCR) rates for patiënten met HR+/HER2- high-risk, early-stage breast cancer (EBC) by cl...

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-02

EFS naar RCB met pembrolizumab bij vroeg TNBC: KEYNOTE-522 analyse

Annals of oncology : official journal of the European Society for Medical Oncology · 2024-05

Vroeg mammacarcinoom: ESMO 2024 richtlijn

Annals of oncology : official journal of the European Society for Medical Oncology · 2024-02

Treatment Efficacy Score: continue RCB-metric bij neoadjuvant mammacarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2022-08

Voorspelde endocriene therapiegevoeligheid bij stadium II-III HR+/HER2- mammacarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2021-05

Pathway-alteraties versus individuele mutaties als voorspellers van respons op anti-HER2 therapie: neo-ALTTO analyse

Annals of oncology : official journal of the European Society for Medical Oncology · 1 januari 2017